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ScienceDirectWe know more about the repertoire of cellular behaviours that
define the stem and progenitor cells maintaining the intestinal
epithelium than any other renewing tissue. Highly dynamic and
stochastic processes define cell renewal. Historically the
commitment step in differentiation is viewed as a ratchet,
irreversibly promoting a given fate and corresponding to a
programme imposed at the point of cell division. However, the
emerging view of intestinal self-renewal is one of plasticity in
which a stem cell state is easily reacquired. The pathway
mediators of lineage selection are largely known but how they
interface within highly dynamic populations to promote
different lineages and yet permit plasticity is not. Advances in
understanding gene regulation in the nervous system suggest
possible mechanisms.
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Introduction
The sheet of cells that comprises the small intestinal
epithelium is indented to create glandular crypts in
which cell proliferation is restricted and from which all
cell types are generated. Absorptive enterocytes and
secretory (Goblet and enteroendocrine) cells actively
migrate from crypts while undergoing a phenotypic
maturation that is accompanied by a restricted number
of transient cell divisions (Figure 1). The most morpho-
logically undifferentiated cells are located at or near the
crypt base where they interface with long-lived differ-
entiated secretory Paneth cells. These undifferentiated
cells are maintained by robust levels of active Wnt
signalling, characterised by expression of Lgr5 (a R-
spondin receptor) and contain much of, and arguably
all, the steady-state stem cell activity as shown by lineagewww.sciencedirect.com tracing. The colonic epithelium has similar organisation
but lacks both villi and Paneth cells.
There are differences in the properties of cells in the
crypt base which are recognised by heterogeneous
expression of markers and that arises from both the
geography of the lower crypt and the availability of
Paneth cells for cell-cell interaction. Together these
factors create a nuanced biology; undifferentiated
cells immediately above the Paneth cell region (at, or
around, cell position 4 from the crypt base) tend to
express different markers than those within it. The cells
within these different zones have been proposed as
alternative candidates for the stem cell population.
Position specific heterogeneity in marker expression
and in properties such as quiescence has previously
been interpreted as indicative of relatively stable sub-
populations moving unidirectionally through discrete
cellular intermediates from multipotent stem cells to
committed progeny. However, recent evidence for
plasticity challenges this interpretation and suggests
that normal cell fates are easily altered and stemness
regained.
Intestinal lineage specification by Notch and
the bHLH proteins
Historically attempts to explain how multiple phenoty-
pically distinct cell types arise within the crypt have
assumed the creation of lineage-restricted progenitors
that can be distinguished by different transcription factor
profiles [1,2]. Commitment has been viewed as a series of
binary decisions, the first directing absorptive versus a
‘pan’ secretory fate, followed by further diversification
into the four principal secretory types [3].
Several key bHLH ‘proneural’ proteins play distinct and
crucial roles in early lineage specifications as well as
differentiation events in the crypt, and their expression
and activity are spatially and temporally regulated
(Figure 1). A large part of this regulation appears to be
via the Notch signalling pathway [4–7].
Ultimately Notch signalling regulates the stem versus
secretory fate decision as well as further fate choice and
differentiation events in the crypt [8,9]. Expression of the
proneural bHLH transcription factor Ascl2 is associated
with stemness and is absolutely required for intestinal
stem cell maintenance. Active Notch is required for Ascl2
expression and its loss results in precocious crypt cell
differentiation [8,10]. The proneural protein Atoh1 acts as
a master regulator of fate specification of the secretory
lineage [2,11]. Ascl2 expression is maintained by activeCurrent Opinion in Cell Biology 2014, 31:39–45
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Organisation and lineage control in the intestine. (a) H&E section of
intestine showing crypt-to-villus axis. Expanded view of crypt shown
alongside a schematic showing the location of the different functional
zones. (b) Schematic of classical view of bHLH transcription factor-
driven control of fate choice and differentiation in the intestine, and a
simplified view of their regulation by Notch signalling. However, complex
interaction between cells, potential oscillating expression of bHLHs, and
a clear ability to move back up the hierarchy towards stemness, points
strongly to a great deal of potential for plasticity, rather than cells
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Schematic of the Notch signalling pathway. In brief, activation of the
Notch membrane receptor requires binding by a member of the
membrane-bound ligand Delta family (primarily Delta-like, Dll 1 and 4
and Jag 1 in the crypt) [9]. Binding of ligand to the receptor leads to
release of the Notch intracellular domain (ICD) by protein cleavage. NICD
translocates to the nucleus and associates with the CSL complex (CBF-
1/RBP-J, Su(H), Lag1), displacing transcriptional repressors. This
complex now associates with transcriptional co-regulators of the MAML
family, resulting in upregulation of multiple downstream targets including
Hes (Hairy/Enhancer of Split) proteins. Notch signalling via Hes proteins
act to potentiate stem cell maintenance and inhibit secretory via
regulation of bHLH transcription factors. For many more details see [5].Notch signalling that also acts to suppress Atoh1. Expres-
sion of Atoh1 is cell-autonomously inhibited by Hes
proteins and in the absence of Notch signalling, crypt
stem cells precociously differentiate into secretory goblet
cells [7,12].
The spatial organisation of cells expressing Notch ligand
and receptor in the crypt evokes a classic lateral inhibition
scenario for control of stem versus secretory fate
(Figure 2). Stem cells towards the crypt base found
preferentially adjacent to Delta-expressing Paneth cells,
express Notch receptor [13,14], and are maintained in an
undifferentiated state by constant Notch signalling and
suppression of Atoh1 [7,9,15,16], As migrating cells lose
contact with Paneth cells and the high Notch signalling
they confer, they become poised between secretory and
non-secretory fate. Lineage selection may then arise by
stochastic variation in Delta expression leading some cells
to express higher levels than others. This initial stochastic
imbalance in Delta expression becomes reinforced allow-
ing only a subset of cells (Delta high, Atoh high) rising up
the crypt to become committed to a secretory fate while
the rest become absorptive enterocytes.Current Opinion in Cell Biology 2014, 31:39–45 This regulation and functional organisation readily
explains a binary fate in a supra-Paneth cell poised
population but fits less well with a subsequent down-
stream cascade of secretory lineage choices specified after
a series of cell divisions each progressing unidirectionally
towards a more restricted fate. Moreover, recent evidence
derived from regenerating systems casts doubt both on
the existence of stable populations of progenitors and the
irreversibility of lineage specification.
Plasticity
For many years it has also been known that intestinal
regeneration following damage is not solely a function of
surviving stem cells expanding to restore homeostasis
(Figure 3) [17]. Following radiation induced injury the
clonogenic fraction of crypt cells is elevated suggesting that
these might correspond to the abundant and immature
absorptive cells present within the early transit-amplifyingwww.sciencedirect.com
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Schematic showing routes for stem cell restoration. Normal
differentiation (black arrows) follows unidirectional lineage choice via
intermediates. Stem cells occupy a sustaining environment created by
Paneth cells (grey box). Following damage regenerative processes allow
stemness to be regained (solid red arrows) from immediate stem cell
descendants. Experimental upregulation of pathways shown can act to
effect lineage fates from differentiated cells (dashed arrows).compartment of the lower crypt. In support, specific abla-
tion of the key Lgr5+ population using targeted diptheria
toxin is not catastrophic as non-Lgr5+ cells (Bmi1+) cells
are able to act as a replacement stem cell pool at least for a
limited time [18]. Strikingly though, Lgr5+ cells do appear
to be essential for intestinal regeneration after irradiation,
indicating that context of either the initial damage and/or
the subsequent regenerative response may reveal plasticity
in different populations [19]. Even in steady state con-
ditions, some interconversion occurs between Lgr5+ cells
and cells residing at higher crypt levels, defined by Hopx
expression indicating a ready accessibility of early com-
mitted cells to the stem compartment [20].
Recent discoveries indicate more dramatic plasticity
within the absorptive lineage (Figure 3). Hyperactivation
of pathways synergising with Wnt signalling are appar-
ently able to generate stem cells as part of an oncogenic
process even within terminally differentiated villus cells
[21]. Hyper-elevation of NF-kB signalling, by deletion
of negative regulators of the pathway, synergises with
Wnt signalling, elevating targets such as Ascl2 and leading
to ectopic formation in villi of crypt-like structures
expressing stem cell markers [21,22]. Further 3-D
spheroid culture of isolated villi confirms the potential
of these cells to proliferate over several passages and show
multilineage differentiation in xenografts.www.sciencedirect.com Evidence that secretory progenitors can also contribute to
regeneration comes from functional studies of cells
expressing Delta-like 1 (see below). Lineage tracing in
Dll1-CreER mice following Tamoxifen treatment
demonstrates that single Dll1+ cells in the steady state
give rise mainly to short lived secretory clones [13].
Equivalent lineage tracing following damage shows that
many Dll1+ cells can give rise to long lived clones
comprising both absorptive and secretory lineages,
demonstrating that they have regained stem cell activity
[13]. Further, elevated Notch signalling in intestinal villi
can cause phenotypic switching of mature differentiated
cells from an absorptive to secretory lineage [23].
Subsequently the status of quiescent or label-retaining
cells (LRCs) in the epithelium was investigated using a
conditionally expressed, histone-conjugated fluorescent
protein (H2BYFP) that could be widely induced initially
and subsequently retained in cells that are quiescent [24].
Characterisation of isolated YFP-LRCs shows these cells
have a secretory signature associated with Paneth and
enteroendocrine cells. Moreover, inheritance of the label
into these cell types is observed over time. Functional
lineage tracing of these YFP-LRCs shows that they do not
normally give rise to multilineage clones but do so after
regenerative stimuli. Together these findings suggest that
quiescent cells are committed to become Paneth and
enteroendocrine cells but after damage and regeneration
are capable of reacquiring stem cell potential.
In summary both absorptive and secretory lineages dis-
play plasticity in experimental settings. For cells of either
type, plasticity requires responsive cells not only to
proliferate but also to demonstrate acquisition of the
opposing phenotype, that is, multipotentiality.
Notch and bHLH proteins regulate cell fate
and plasticity
The classical model of Notch-mediated lateral inhibition,
whereby initially equivalent cells interact with each other
to adopt alternative fates, was originally formulated to
describe the specification of individual neural precursors
from an equivalence group of cells under the control of a
network of bHLH proneural transcription factors and Hes
proteins, analogous to those in the gut [25]. Yet this model
notably fails to explain intestinal plasticity where the
reverse applies, that is, the acquisition of stem cell
‘equivalence’ from phenotypically diverse cells. Again,
advances in our understanding of mammalian neurogen-
esis indicate the potential for a more dynamic regulation
of these types of specification events than originally
proposed that may help explain intestinal plasticity.
In the mammalian nervous system, expression of the pro-
neural bHLH transcription factors Ngn2 and Ascl1 oscillates
with a periodicity of 2–3 hours in neural stem/progenitor
cells. Oscillations are controlled by a transcriptional doubleCurrent Opinion in Cell Biology 2014, 31:39–45
42 Cell cycle, differentiation and diseasenegative feedback loop; the proneural transcription factors
control expression of Delta-like ligands, activating Notch
signalling and consequently resulting in delayed anti-
phased expression of short-lived repressors (the Hes
proteins) [26,27]. Such Notch/Delta-mediated inter-
actions between adjacent cells result in reciprocal Delta,
bHLH and Hes oscillations where neighbours are out of
synchrony and progenitor maintenance prevails [27,28].
Cessation of oscillations of both proneural and Hes proteins
coincides with fate choice decisions, and results in sustained
high expression of proneural proteins to drive differen-
tiation, with reciprocal sustained low expression of Hes
inhibitors. Indeed, in the nervous system stable, as opposed
to oscillatory, bHLH expression seems to be absolutely
required for cells to exit the cell cycle and adopt a differ-
entiated fate [27,28,29]. As the essential players in fate
decisions in the crypt are highly analogous to those in the
nervous system, it seems likely that such oscillatory expres-
sion of proneural and Hes proteins also occurs in the
















































Potential interaction nodes for intestinal lineage specification. (a) In the cryp
signalling in stem cells is sustained by long lived secretory cells expressing
allows cells to move between lineage poised fates (secretory and absorptiv
lineage committed. Stem potentiality following damage/regeneration by: (1) r
key pathways such as Wnt/NFkB in committed cells. (3) In experimental/extr
initiation of Notch signalling (b,c). Potential molecular circuitry linking Notch
Atoh1/Ngn3 (C), based on known direct and indirect interactions [5,7–10,29
evidence in the intestine. Dotted blue lines indicate relationships inferred fro
transcription factors. Grey arrows and text indicate protein instability; where 
and sometimes exceptionally short, half lives. The delayed negative feedbac
analogous Hes and bHLH proteins in neural stem cells [29].
Current Opinion in Cell Biology 2014, 31:39–45 and is itself repressed by Notch and Hes activity [5,9], so is
well-placed to be part of a similar double negative feedback
loop driving oscillatory expression as is seen for Hes1, Ngn2
and Ascl1 (Figure 4) [29,30]. Active Notch is required for
Ascl2 expression but may also have contradictory effects as
Hes1 has been described as suppressing Ascl2’s expression
in epidermal cells [31]. Ascl2 can also be directly activated
by Wnt and has a crucial role in maintaining stemness
[8,10,31]. Speculatively, oscillatory expression of Ascl2
may be required for this function, as is the case for Ascl1
and neural stem cell maintenance.
Where in the crypt stem/progenitor pool might such
oscillations operate? This will be hard to determine in
vivo with current methodologies, as all oscillatory expres-
sion will probably fall beneath the detection threshold of
common visualisation techniques [26,27]. There may be
clues however from studies of Dll1 where in situ hybrid-
isation indicates that high (and maybe stable) Delta
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t base cells are maintained in a WntHi environment in which high Notch
 Delta-like ligands. In suprabasal crypt positions oscillatory expression
e). This resolves stochastically and at higher crypt positions cells are
estored interactions with Dll1 expressing cells; (2) by hyper stimulation of
eme settings mature cells expressing Delta ligand may promote local re-
 signalling and bHLH transcription factor expression for Ascl2 (B) and
,31,33,43–45]. Solid blue arrows denote relationships supported by
m the same gene in other tissues or by analogy to closely related bHLH
studied, these bHLHs and Hes proteins have been shown to have short,
k loop in (B) has been shown to result in oscillatory expression of
www.sciencedirect.com
Intestinal plasticity and lineages Philpott and Winton 43that also express high levels of Atoh1 (Figure 4) [13].
Low-level oscillations may occur at the lower cell posi-
tions containing the intercalated, Lgr5+ population.
Additionally, lower levels of Delta are seen in individual
cells higher in the crypt and even on the villus (though the
bHLH and Hes proteins are not), commensurate with
Notch signalling playing roles later in the specification/
differentiation programme (see below) [13].
Notch also regulates Ngn3, a bHLH that is absolutely
required for secretory cells to adopt enteroendocrine fate
[32]. The molecular mechanism of regulation of Ngn3 by
Notch signalling is analogous to the regulation of Atoh1 as
well as Ngn2 in the nervous system; where Notch acti-
vation inhibits Ngn3 expression, suppressing enteroen-
docrine cell formation and promoting alternate enterocyte
or goblet fates [7,33,34]. It is striking that enteroendo-
crine numbers are limited but not eliminated by Notch
activation in Ngn3 positive cells while Notch activation
driven by the villin promoter, that acts earlier in crypt
specification results in complete enteroendocrine cell loss
showing context-dependence of Notch sensitivity
[33,35].
Concluding remarks
In terms of plasticity the iterative role of Notch signal-
ling means that the pathway is accessible to cells
throughout the crypt to villus axis. After epithelial cell
depletion, surviving cells have a number of options to
be restored to a stem cell state. At the level of an
individual cell this may require regaining low-level
oscillatory Notch signals associated with the poised
state perhaps by altering the stability or post-transla-
tional regulation of the bHLH proteins that promote
fate decisions [36]. Alternatively, in maturing entero-
cytes [37,38], upregulation of Hes family proteins could
actively promote Ascl2 while suppressing Atoh1 expres-
sion and function. Notably the Ascl2 axis with poten-
tially competing roles for elements of the Notch
pathway also allows input and crosstalk from the Wnt
pathway. Cell interactions favouring acquisition of
stemness might include occupying a vacant cell position
adjacent to a DeltaHi expressing cell to promote active
Notch signalling in neighbours.
The outline circuitry defined by the bHLH/Hes axis
regulation can be fleshed out by a variety of post-tran-
scriptional interactions and modification to limit or
potentiate available Notch signalling in a context de-
pendent manner. For example Notch transcript itself
can be sequestered by regulatory microRNAs such as
miR-34a. Downregulation of miR-34a following damage
could promote not only acquisition of stemness but allow
for rapid expansion of stem cells by symmetric divisions
[39]. Post-translational interactions such as Numb-
mediated degradation of membrane-bound Notch or
translational inhibition of Numb by RNA bindingwww.sciencedirect.com proteins such as Musashi1 could similarly act to inhibit
or promote Notch signalling respectively [40,41].
Finally, recently it has been shown that the chromatin
status cells of secretory and absorptive progenitors remain
constant. It is likely that throughout the crypt the palette
of accessible loci remains unchanged with lineage choice
making the restoration of stemness from maturing cell
types purely dependent on expression on key transcrip-
tion factors [42]. In confirming the dependency of the
epithelium on bHLH family members attention must
turn to determining their modes of expression and how
these are regulated to achieve different outcomes in
different contexts including both in homeostasis and
the plasticity associated with regeneration.
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